Health Technology Assessment (HTA)
Health Technology Assessment (HTA) is a multidisciplinary process that uses explicit methods to determine a health technology’s value for healthcare decision-making. Attitudes towards HTA vary globally, with some countries using a variety of methods and analyses and others hardly any.
The Future of NICE in a Changing HTA Landscape
11 March 2024
To commemorate NICE’s 25th anniversary, this OHE webinar explored the biggest challenges and opportunities for the NICE HTA program over the next 5-10 years.
Incorporating the Patient Voice in Health Technology Assessment
15 February 2024
The decision to adopt or not adopt a new healthcare technology, and the process by which this decision is made, affects patients, the health system, and wider society. In this Whitepaper, we suggest that the patient perspective is critical to making fully-informed decisions about the value of new technologies, but this perspective has not always been given the same weight as clinical and economic aspects in health technology assessment (HTA).
Looking Further Afield – What Can Health Economics Learn from the Environmental Economics Approach to Discounting?
1 February 2024
Discounting in economic evaluations presents challenges for therapies with high up-front costs and long-term benefits. We discuss how health economics can learn from debates occurring within environmental economics, where discounting poses similar challenges.
Around The World in HTAs: Türkiye – The bumpy road toward transformation
31 January 2024
In this Insights series, Around the World in HTAs, we shed light on HTA around the world. In this edition, Prof Hasan Huseyin Yildirim, Dilek Sernur Eminoğulları, Dr Tuba Saygın Avşar, and Patricia Cubi-Molla take us to Türkiye.
Navigating the Intersection of Healthcare and Environmental Sustainability: ISPOR Europe round-up on the inclusion of environmental impact in HTA
17 January 2024
In this insight, commissioned and funded by Chiesi S.p.A, we reflect on the discussions that took place at ISPOR Europe 2023 and how environmental impact is factored into HTA.
Capturing the Broader Value of Antibiotics
23 November 2023
The value of antibiotics often extends beyond what HTA captures. The STEDI framework aims to capture that broader value and our report outlines a roadmap to realising its full potential.
Innovation for Health System Efficiency and Improvement
20 November 2023
In this report, commissioned and funded by Gilead, we explore the role of innovation in developing healthcare system efficiency amid post-pandemic challenges.
Around The World in HTAs: Greece – Late but with an Optimistic Future
18 October 2023
In this Insights series, Around the World in HTAs, we shed light on HTA around the world. In this edition, Athanassios Vozikis and Dimitrios Kourouklis take us to Greece.
NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?
18 September 2023
In this report, we explore the potential impact of the National Institute of Health and Care Excellence (NICE) decision outcomes on healthcare decision-making in 12 countries across the globe (Australia, Brazil, Canada, France, Italy, Israel, Japan, South Korea, Poland, Saudi Arabia, Sweden, and the United Arab Emirates). We used quantitative and qualitative methods to estimate the level of impact and potential underlying mechanisms.